HEART UK is supported by experts who guide and advise various aspects of our work. 

Medical, Scientific and Research Committee

Chaired by Dr Handrean Soran, Consultant Physician & Endocrinologist, Department of Medicine, Manchester University Hospitals NHS Foundation Trust

Oversee the Annual Conference, the development of research and speciality training programmes,  allocation of research awards and clinical guideline development

HEART UK's CVD Collaborative

Chaired by Jules Payne, Chief Executive

Advises on public affairs and policy activities to highlight the importance of cholesterol and CVD. Membership includes Amgen, Bayer, Daiichi Sankyo and Novartis and an annual membership fee is paid. All final decisions remain with HEART UK and members have no editorial control over the content or outputs of the Group’s work. 

HEART UK Primary Care Education Programme Advisory Group

Chaired by Jules Payne, Chief Executive

Advises on the development and implementation of an education programme for primary care healthcare professionals and further the objectives of the charity to provide learning opportunities on lipid management.

Membership includes Boehringer Ingelheim, Novartis and Sanofi and an annual fee is paid. All final decisions remain with HEART UK and members have no editorial control over the content or outputs of the Primary Care Education Programme Advisory Group’s work.”

Healthcare Committee

Chaired by Michaela Nuttall, Cardiovascular Nurse Specialist

Provides up-to-date information to health care professionals who care for patients and their families with lipid disorders and co-organise the Annual Conference.


Lipid Interest Group

Chaired by Alison Pottle, Nurse Consultant in Cardiology, Harefield Hospital

Education, networking, promoting information and support for people with an interest in lipids i.e. nurses, dieticians across both primary and secondary care.

Lipoprotein Apheresis Working Group

Chaired by Dr Dev Datta, Consultant in Metabolic Medicine, University Hospital of Wales, Cardiff

To promulgate guidance regarding the clinical indications for undertaking lipoprotein apheresis and the criteria of efficacy of its performance in the UK.

Assessment of the latter will be based upon data collected in a Registry, which is set up under the aegis of HEART UK and the Royal College of Physicians.  Also to widen the knowledge about Apheresis as a treatment.

Product Approval Working Group

Evaluates products for approval following an ethical and scientific policy framework.

Simon Broome Steering Committee

Chaired by Dr Nigel Capps, Consultant Chemical Pathologist Shrewsbury and Telford Hospital NHS Trust

Responsible for directing research based on a national cohort of over 3,500 patients and familial hypercholesterolaemia.  The Sub-Committee is composed of clinical academics, geneticists and clinicians.